{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:47:58Z","timestamp":1788317278047,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203034"],"award-info":[{"award-number":["82203034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073371"],"award-info":[{"award-number":["82073371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Science and Technology Project of Yunnan Province","doi-asserted-by":"crossref","award":["202201AT070238"],"award-info":[{"award-number":["202201AT070238"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project in Basic Research of Yunnan Province","award":["202401BC070009"],"award-info":[{"award-number":["202401BC070009"]}]},{"name":"Yunnan Province Major Science and Technology Special Project","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03471-2","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T09:47:03Z","timestamp":1749376023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor microenvironment remodeling with a telomere-targeting agent and its cooperative antitumor effects with a nanovaccine"],"prefix":"10.1186","volume":"23","author":[{"given":"Jing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,8]]},"reference":[{"issue":"3","key":"3471_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3471_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mc.23035","volume":"58","author":"ET Sugarman","year":"2019","unstructured":"Sugarman ET, Zhang G, Shay JW. In perspective: an update on telomere targeting in cancer. Mol Carcinog. 2019;58(9):1581\u20138.","journal-title":"Mol Carcinog"},{"issue":"8","key":"3471_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/ijms20081823","volume":"20","author":"E Mizukoshi","year":"2019","unstructured":"Mizukoshi E, Kaneko S. Telomerase-targeted cancer immunotherapy. Int J Mol Sci. 2019;20(8):1823.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3471_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/13543776.2016.1181172","volume":"26","author":"RJ Man","year":"2016","unstructured":"Man RJ, Chen LW, Zhu HL. Telomerase inhibitors: a patent review (2010\u20132015). Expert Opin Ther Pat. 2016;26(6):679\u201388.","journal-title":"Expert Opin Ther Pat"},{"issue":"8","key":"3471_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.neo.2018.06.002","volume":"20","author":"I Mender","year":"2018","unstructured":"Mender I, LaRanger R, Luitel K, Peyton M, Girard L, Lai TP, Batten K, Cornelius C, Dalvi MP, Ramirez M, Du W, Wu LF, Altschuler SJ, Brekken R, Martinez ED, Minna JD, Wright WE, Shay JW. Telomerase-mediated strategy for overcoming non-small cell lung cancer targeted therapy and chemotherapy resistance. Neoplasia. 2018;20(8):826\u201337.","journal-title":"Neoplasia."},{"issue":"7","key":"3471_CR6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-17-0792","volume":"17","author":"S Sengupta","year":"2018","unstructured":"Sengupta S, Sobo M, Lee K, Senthil Kumar S, White AR, Mender I, Fuller C, Chow LML, Fouladi M, Shay JW, Drissi R. Induced telomere damage to treat telomerase expressing therapy-resistant pediatric brain tumors. Mol Cancer Ther. 2018;17(7):1504\u201314.","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"3471_CR7","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1158\/1078-0432.CCR-17-2773","volume":"24","author":"G Zhang","year":"2018","unstructured":"Zhang G, Wu LW, Mender I, Barzily-Rokni M, Hammond MR, Ope O, Cheng C, Vasilopoulos T, Randell S, Sadek N, Beroard A, Xiao M, Tian T, Tan J, Saeed U, Sugarman E, Krepler C, Brafford P, Sproesser K, Murugan S, Somasundaram R, Garman B, Wubbenhorst B, Woo J, Yin X, Liu Q, Frederick DT, Miao B, Xu W, Karakousis GC, Xu X, Schuchter LM, Mitchell TC, Kwong LN, Amaravadi RK, Lu Y, Boland GM, Wei Z, Nathanson K, Herbig U, Mills GB, Flaherty KT, Herlyn M, Shay JW. Induction of telomere dysfunction prolongs disease control of therapy-resistant melanoma. Clinical Cancer Res Off J Am Assoc Cancer Res. 2018;24(19):4771\u201384.","journal-title":"Clinical Cancer Res Off J Am Assoc Cancer Res"},{"issue":"24","key":"3471_CR8","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1158\/1078-0432.CCR-21-0374","volume":"27","author":"S Yu","year":"2021","unstructured":"Yu S, Wei S, Savani M, Lin X, Du K, Mender I, Siteni S, Vasilopoulos T, Reitman ZJ, Ku Y, Wu D, Liu H, Tian M, Chen Y, Labrie M, Charbonneau CM, Sugarman E, Bowie M, Hariharan S, Waitkus M, Jiang W, McLendon RE, Pan E, Khasraw M, Walsh KM, Lu Y, Herlyn M, Mills G, Herbig U, Wei Z, Keir ST, Flaherty K, Liu L, Wu K, Shay JW, Abdullah K, Zhang G, Ashley DM. A modified nucleoside 6-Thio-2\u2019-deoxyguanosine exhibits antitumor activity in gliomas. Clin Cancer Res Off J Am Assoc Cancer Res. 2021;27(24):6800\u201314.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"3471_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1158\/2159-8290.CD-14-0609","volume":"5","author":"I Mender","year":"2015","unstructured":"Mender I, Gryaznov S, Dikmen ZG, Wright WE, Shay JW. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2\u2019-deoxyguanosine. Cancer Discov. 2015;5(1):82\u201395.","journal-title":"Cancer Discov"},{"issue":"8","key":"3471_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.18632\/oncoscience.213","volume":"2","author":"I Mender","year":"2015","unstructured":"Mender I, Gryaznov S, Shay JW. A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells. Oncoscience. 2015;2(8):693\u20135.","journal-title":"Oncoscience"},{"issue":"3","key":"3471_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ccell.2020.05.020","volume":"38","author":"I Mender","year":"2020","unstructured":"Mender I, Zhang A, Ren Z, Han C, Deng Y, Siteni S, Li H, Zhu J, Vemula A, Shay JW, Fu YX. Telomere stress potentiates STING-dependent anti-tumor immunity. Cancer Cell. 2020;38(3):400-411.e6.","journal-title":"Cancer Cell"},{"issue":"4","key":"3471_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500.","journal-title":"Nat Immunol"},{"issue":"12","key":"3471_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"3471_CR14","doi-asserted-by":"publisher","first-page":"e2201734","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci. 2022;9(22):e2201734.","journal-title":"Adv Sci"},{"issue":"11","key":"3471_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3471_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/cells11091415","volume":"11","author":"AI Birmpilis","year":"2022","unstructured":"Birmpilis AI, Paschalis A, Mourkakis A, Christodoulou P, Kostopoulos IV, Antimissari E, Terzoudi G, Georgakilas AG, Armpilia C, Papageorgis P, Kastritis E, Terpos E, Dimopoulos MA, Kalbacher H, Livaniou E, Christodoulou MI, Tsitsilonis OE. Immunogenic cell death, DAMPs and Prothymosin \u03b1 as a putative anticancer immune response biomarker. Cells. 2022;11(9):1415.","journal-title":"Cells"},{"issue":"8","key":"3471_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41419-019-1819-3","volume":"10","author":"K Tatsuno","year":"2019","unstructured":"Tatsuno K, Yamazaki T, Hanlon D, Han P, Robinson E, Sobolev O, Yurter A, Rivera-Molina F, Arshad N, Edelson RL, Galluzzi L. Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death Dis. 2019;10(8):578.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3471_CR18","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994\u20133006.","journal-title":"Mol Oncol"},{"issue":"4","key":"3471_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/cells10040930","volume":"10","author":"RDW Vaes","year":"2021","unstructured":"Vaes RDW, Hendriks LEL, Vooijs M, De Ruysscher D. Biomarkers of radiotherapy-induced immunogenic cell death. Cells. 2021;10(4):930.","journal-title":"Cells"},{"key":"3471_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-017-0234-5","volume":"5","author":"R Nuccitelli","year":"2017","unstructured":"Nuccitelli R, McDaniel A, Anand S, Cha J, Mallon Z, Berridge JC, Uecker D. Nano-pulse stimulation is a physical modality that can trigger immunogenic tumor cell death. J Immunother Cancer. 2017;5:32.","journal-title":"J Immunother Cancer"},{"issue":"41","key":"3471_CR21","doi-asserted-by":"publisher","first-page":"17218","DOI":"10.1039\/D1NR05512G","volume":"13","author":"M Jiang","year":"2021","unstructured":"Jiang M, Zeng J, Zhao L, Zhang M, Ma J, Guan X, Zhang W. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy. Nanoscale. 2021;13(41):17218\u201335.","journal-title":"Nanoscale"},{"issue":"6","key":"3471_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.4078","volume":"22","author":"C Pozzi","year":"2016","unstructured":"Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, Cancelliere C, Di Fiore PP, Bardelli A, Penna G, Rescigno M. The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death. Nat Med. 2016;22(6):624\u201331.","journal-title":"Nat Med"},{"issue":"12","key":"3471_CR23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1084\/jem.20050915","volume":"202","author":"N Casares","year":"2005","unstructured":"Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, M\u00e9tivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med. 2005;202(12):1691\u2013701.","journal-title":"J Exp Med"},{"issue":"2","key":"3471_CR24","first-page":"214","volume":"46","author":"M Wang","year":"2024","unstructured":"Wang M, Duan B, Bai J, Luo Y, Ma Y. Telomerase inhibitor 6-Thio-2\u2019-deoxyguanosine induces immunogenic cell death in tumour cells. Chin J Cell Biol. 2024;46(2):214\u201325.","journal-title":"Chin J Cell Biol"},{"issue":"4","key":"3471_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","volume":"66","author":"KR Jordan","year":"2017","unstructured":"Jordan KR, Kapoor P, Spongberg E, Tobin RP, Gao D, Borges VF, McCarter MD. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Cancer Immunol Immunother CII. 2017;66(4):503\u201313.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"18","key":"3471_CR26","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","volume":"11","author":"E Suzuki","year":"2005","unstructured":"Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(18):6713\u201321.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"47","key":"3471_CR27","doi-asserted-by":"publisher","first-page":"2002085","DOI":"10.1002\/adma.202002085","volume":"32","author":"S Qing","year":"2020","unstructured":"Qing S, Lyu C, Zhu L, Pan C, Wang S, Li F, Wang J, Yue H, Gao X, Jia R, Wei W, Ma G. Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy. Adv Mater. 2020;32(47):2002085.","journal-title":"Adv Mater"},{"issue":"43","key":"3471_CR28","doi-asserted-by":"publisher","first-page":"2103923","DOI":"10.1002\/adma.202103923","volume":"33","author":"L Hua","year":"2021","unstructured":"Hua L, Yang Z, Li W, Zhang Q, Ren Z, Ye C, Zheng X, Li D, Long Q, Bai H, Sun W, Yang X, Zheng P, He J, Chen Y, Huang W, Ma Y. A Novel Immunomodulator delivery platform based on bacterial biomimetic vesicles for enhanced antitumor immunity. Advanced Mater. 2021;33(43):2103923.","journal-title":"Advanced Mater"},{"key":"3471_CR29","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.2147\/IJN.S214525","volume":"14","author":"S Li","year":"2019","unstructured":"Li S, Zhang Q, Bai H, Huang W, Shu C, Ye C, Sun W, Ma Y. Self-assembled nanofibers elicit potent HPV16 E7-specific cellular immunity and abolish established TC-1 graft tumor. Int J Nanomed. 2019;14:8209\u201319.","journal-title":"Int J Nanomed"},{"issue":"5","key":"3471_CR30","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1039\/C9NR10334A","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Zhu W, Ye C, Sun W, Xie H, Yang X, Zhang Q, Ma Y. Local mucosal immunization of self-assembled nanofibers elicits robust antitumor effects in an orthotopic model of mouse genital tumors. Nanoscale. 2020;12(5):3076\u201389.","journal-title":"Nanoscale"},{"issue":"4","key":"3471_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707\u201323.","journal-title":"Cell"},{"issue":"5","key":"3471_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"7559","key":"3471_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 2015;523(7559):231\u20135.","journal-title":"Nature"},{"key":"3471_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2019.10.052","volume":"316","author":"Y Huang","year":"2019","unstructured":"Huang Y, Shi Y, Wang Q, Qi T, Fu X, Gu Z, Zhang Y, Zhai G, Zhao X, Sun Q, Lin G. Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. J Controll Release Off J Controlled Release Soc. 2019;316:208\u201322.","journal-title":"J Controll Release Off J Controlled Release Soc"},{"issue":"7","key":"3471_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrd2081","volume":"5","author":"JW Shay","year":"2006","unstructured":"Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discovery. 2006;5(7):577\u201384.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"3471_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrc2275","volume":"8","author":"CB Harley","year":"2008","unstructured":"Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008;8(3):167\u201379.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3471_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell. 2015;28(6):690\u2013714.","journal-title":"Cancer Cell"},{"issue":"3","key":"3471_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","volume":"8","author":"L Zitvogel","year":"2011","unstructured":"Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol. 2011;8(3):151\u201360.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3471_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2008;8(1):59\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3471_CR40","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andr\u00e9 F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050\u20139.","journal-title":"Nat Med"},{"issue":"9","key":"3471_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/v13091747","volume":"13","author":"T Gianni","year":"2021","unstructured":"Gianni T, Leoni V, Sanapo M, Parenti F, Bressanin D, Barboni C, Zaghini A, Campadelli-Fiume G, Vannini A. Genotype of immunologically hot or cold tumors determines the antitumor immune response and efficacy by fully virulent retargeted oHSV. Viruses. 2021;13(9):1747.","journal-title":"Viruses"},{"issue":"8","key":"3471_CR42","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/cti2.1335","volume":"10","author":"G Ni","year":"2021","unstructured":"Ni G, Yang X, Li J, Wu X, Liu Y, Li H, Chen S, Fogarty CE, Frazer IH, Chen G, Liu X, Wang T. Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8(+) T cells in the tumor microenvironment. Clin Trans Immunol. 2021;10(8):1335.","journal-title":"Clin Trans Immunol"},{"issue":"18","key":"3471_CR43","doi-asserted-by":"publisher","first-page":"eaax7881","DOI":"10.1126\/sciadv.aax7881","volume":"6","author":"MZ Noman","year":"2020","unstructured":"Noman MZ, Parpal S, Van Moer K, Xiao M, Yu Y, Viklund J, De Milito A, Hasmim M, Andersson M, Amaravadi RK, Martinsson J, Berchem G, Janji B. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1\/PD-L1 immunotherapy. Sci Adv. 2020;6(18):eaax7881.","journal-title":"Sci Adv"},{"issue":"8","key":"3471_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024226","volume":"6","author":"T Akimova","year":"2011","unstructured":"Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS ONE. 2011;6(8): e24226.","journal-title":"PLoS ONE"},{"issue":"4","key":"3471_CR45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27(4):462\u201372.","journal-title":"Cancer Cell"},{"issue":"1","key":"3471_CR46","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, Lee SW, Gho YS. Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response. Nat Commun. 2017;8(1):626.","journal-title":"Nat Commun"},{"issue":"6","key":"3471_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11095-013-1205-2","volume":"31","author":"R Xing","year":"2014","unstructured":"Xing R, Liu G, Zhu J, Hou Y, Chen X. Functional magnetic nanoparticles for non-viral gene delivery and MR imaging. Pharm Res. 2014;31(6):1377\u201389.","journal-title":"Pharm Res"},{"key":"3471_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2024.135346","volume":"405","author":"H Chen","year":"2024","unstructured":"Chen H, Yan S, Zhang L, Zhao B, Zhu C, Deng G, Liu J. A self-degrading and NIR-II emissive type I\/II photosensitizer with synergistic photodynamic and photothermal properties for antibacterial and anticancer. Sens Actuators B Chem. 2024;405: 135346.","journal-title":"Sens Actuators B Chem"},{"issue":"9","key":"3471_CR49","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1021\/acsnano.3c06987","volume":"18","author":"P Zheng","year":"2024","unstructured":"Zheng P, He J, Fu Y, Yang Y, Li S, Duan B, Yang Y, Hu Y, Yang Z, Wang M, Liu Q, Zheng X, Hua L, Li W, Li D, Ding Y, Yang X, Bai H, Long Q, Huang W, Ma Y. Engineered bacterial biomimetic vesicles reprogram tumor-associated macrophages and remodel tumor microenvironment to promote innate and adaptive antitumor immune responses. ACS Nano. 2024;18(9):6863\u201386.","journal-title":"ACS Nano"},{"issue":"1","key":"3471_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11302-018-9641-4","volume":"15","author":"Y Huang","year":"2019","unstructured":"Huang Y, Gu Z, Fan Y, Zhai G, Zhao X, Sun Q, Shi Y, Lin G. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic Signal. 2019;15(1):53\u201367.","journal-title":"Purinergic Signal"},{"key":"3471_CR51","unstructured":"THIO sequenced with cemiplimab in advanced NSCLC. https:\/\/tinyurl.com\/mr3rjuw3 (Accessed 5 Feb, 2025)."},{"key":"3471_CR52","unstructured":"MAIA Biotechnology announces positive efficacy updates for phase 2 THIO-101 trial in advanced non-small cell lung cancer. https:\/\/tinyurl.com\/ypuvs8e2 (Accessed 5 Feb, 2025)."},{"issue":"49","key":"3471_CR53","doi-asserted-by":"publisher","first-page":"54399","DOI":"10.1021\/acsami.0c15522","volume":"12","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Huang W, Yuan M, Li W, Hua L, Yang Z, Gao F, Li S, Ye C, Chen Y, He J, Sun W, Yang X, Bai H, Ma Y. Employing ATP as a new adjuvant promotes the induction of robust antitumor cellular immunity by a PLGA nanoparticle vaccine. ACS Appl Mater Interf. 2020;12(49):54399\u2013414.","journal-title":"ACS Appl Mater Interf"},{"issue":"2","key":"3471_CR54","doi-asserted-by":"publisher","first-page":"000949","DOI":"10.1136\/jitc-2020-000949","volume":"8","author":"R Weber","year":"2020","unstructured":"Weber R, Riester Z, H\u00fcser L, Sticht C, Siebenmorgen A, Groth C, Hu X, Altevogt P, Utikal JS, Umansky V. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. J Immunother Cancer. 2020;8(2):000949.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"3471_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s43018-020-0061-3","volume":"1","author":"T Li","year":"2020","unstructured":"Li T, Li X, Zamani A, Wang W, Lee CN, Li M, Luo G, Eiler E, Sun H, Ghosh S, Jin J, Murali R, Ruan Q, Shi W, Chen YH. c-Rel Is a myeloid checkpoint for cancer immunotherapy. Nature cancer. 2020;1(5):507\u201317.","journal-title":"Nature cancer"},{"issue":"28","key":"3471_CR56","doi-asserted-by":"publisher","first-page":"32703","DOI":"10.1021\/acsami.1c06701","volume":"13","author":"W Li","year":"2021","unstructured":"Li W, Hu Y, Zhang Q, Hua L, Yang Z, Ren Z, Zheng X, Huang W, Ma Y. Development of drug-resistant Klebsiella pneumoniae vaccine via novel vesicle production technology. ACS Appl Mater Interf. 2021;13(28):32703\u201315.","journal-title":"ACS Appl Mater Interf"},{"issue":"50","key":"3471_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302922","volume":"19","author":"P Zheng","year":"2023","unstructured":"Zheng P, He J, Yang Z, Fu Y, Yang Y, Li W, Ding Y, Yang X, Ma Y. Neoantigen-based nanovaccine in combination with immune checkpoint inhibitors abolish postsurgical tumor recurrence and metastasis. Small. 2023;19(50): e2302922.","journal-title":"Small"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03471-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T13:01:30Z","timestamp":1749387690000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03471-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,8]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3471"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03471-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,8]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of the Institute of Medical Biology, Chinese Academy of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}